KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Other Non-Current Assets (2016 - 2025)

Quest Diagnostics (DGX) has disclosed Other Non-Current Assets for 17 consecutive years, with $270.0 million as the latest value for Q4 2025.

  • Quarterly Other Non-Current Assets rose 5.88% to $270.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $270.0 million through Dec 2025, up 5.88% year-over-year, with the annual reading at $270.0 million for FY2025, 5.88% up from the prior year.
  • Other Non-Current Assets hit $270.0 million in Q4 2025 for Quest Diagnostics, down from $296.0 million in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $296.0 million in Q3 2025 to a low of $132.0 million in Q3 2022.
  • Historically, Other Non-Current Assets has averaged $195.1 million across 5 years, with a median of $173.0 million in 2021.
  • Biggest five-year swings in Other Non-Current Assets: decreased 22.16% in 2022 and later soared 82.55% in 2024.
  • Year by year, Other Non-Current Assets stood at $163.0 million in 2021, then fell by 11.66% to $144.0 million in 2022, then skyrocketed by 37.5% to $198.0 million in 2023, then rose by 28.79% to $255.0 million in 2024, then increased by 5.88% to $270.0 million in 2025.
  • Business Quant data shows Other Non-Current Assets for DGX at $270.0 million in Q4 2025, $296.0 million in Q3 2025, and $271.0 million in Q2 2025.